|
1
|
Ghezzi D, Sevrioukova I, Invernizzi F,
Lamperti C, Mora M, D'Adamo P, Novara F, Zuffardi O, Uziel G and
Zeviani M: Severe X-linked mitochondrial encephalomyopathy
associated with a mutation in apoptosis inducing factor. Am J Hum
Genet. 86:639–649. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Susin SA, Lorenzo HK, Zamzami N, Marzo I,
Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler
M, et al: Molecular characterization of mitochondrial
apoptosis-inducing factor. Nature. 397:441–446. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Joza N, Susin SA, Daugas E, Stanford WL,
Cho SK, Li CY, Sasaki T, Elia AJ, Cheng HY, Ravagnan L, et al:
Essential role of the mitochondrial apoptosis-inducing factor in
programmed cell death. Nature. 410:549–554. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Green DR and Reed JC: Mitochondria and
apoptosis. Science. 281:1309–1312. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Joza N, Pospisilik JA, Hangen E, Hanada T,
Modjtahedi N, Penninger JM and Kroemer G: AIF: Not just an
apoptosis-inducing factor. Ann N Y Acad Sci. 1171:2–11. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shen SM, Guo M, Xiong Z, Yu Y, Zhao XY,
Zhang FF and Chen GQ: AIF inhibits tumor metastasis by protecting
PTEN from oxidation. EMBO Rep. 16:1563–1580. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu SW, Wang H, Poitras MF, Coombs C,
Bowers WJ, Federoff HJ, Poirier GG, Dawson TM and Dawson VL:
Mediation of Poly (ADP-ribose) polymerase-1-dependent cell death by
apoptosis-inducing factor. Science. 297:259–263. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Leslie NR, Yang X, Downes CP and Weijer
CJ: PtdIns(3,4,5)P(3)-dependent and independent roles for PTEN in
the control of cell migration. Curr Biol. 17:115–125. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu CX, Li S and Whorton AR: Redox
regulation of PTEN by S-nitrosothiols. Mol Pharmacol. 68:847–854.
2015.
|
|
10
|
Kim DH, Suh J, Surh YJ and Na HK:
Regulation of the tumor suppressor PTEN by natural anticancer
compounds. Ann N Y Acad Sci. 1401:136–149. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tsai MJ, Chang WA, Tsai PH, Wu CY, Ho YW,
Yen MC, Lin YS, Kuo PL and Hsu YL: Montelukast induces
apoptosis-inducing factor-mediated cell death of lung cancer cells.
Int J Mol Sci. 18:E13532017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ohyama M, Tsuchiya A, Kaku Y, Kanno T,
Shimizu T, Tanaka A and Nishizaki T: Phosphatidylinositol
derivatives induce gastric cancer cell apoptosis by accumulating
AIF and AMID in the nucleus. Anticancer Res. 35:6563–6571.
2015.PubMed/NCBI
|
|
13
|
Xu S, Wu H, Nie H, Yue L, Jiang H, Xiao S
and Li Y: AIF downregulation and its interaction with STK3 in renal
cell carcinoma. PLoS One. 9:e1008242014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo H, German P, Bai S, Barnes S, Guo W,
Qi X, Lou H, Liang J, Jonasch E, Mills GB and Ding Z: The PI3K/AKT
pathway and renal cell carcinoma. J Genet Genomics. 42:343–353.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kuusk T, Grivas N, de Bruijn R and Bex A:
The current management of renal cell carcinoma. Minerva Med.
108:357–369. 2017.PubMed/NCBI
|
|
16
|
Ye DW and Zhang HL: Critical appraisal of
sorafenib in the treatment of Chinese patients with renal cell
carcinoma. Onco Targets Ther. 7:925–935. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li XL, Chen XQ, Zhang MN, Chen N, Nie L,
Xu M, Gong J, Shen PF, Su ZZ, Weng X, et al: SOX9 was involved in
TKIs resistance in renal cell carcinoma via Raf/MEK/ERK signaling
pathway. Int J Clin Exp Pathol. 8:3871–3881. 2015.PubMed/NCBI
|
|
18
|
Heng DY, Xie W, Regan MM, Harshman LC,
Bjarnason GA, Vaishampayan UN, Mackenzie M, Wood L, Donskov F, Tan
MH, et al: External validation and comparison with other models of
the International metastatic renal-cell carcinoma database
consortium prognostic model: A population-based study. Lancet
Oncol. 14:141–148. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li J, Huang JH, Qu QH, Xia Q, Wang DS, Jin
L and Sheng C: Evaluating the microRNA-target gene regulatory
network in renal cell carcinomas, identification for potential
biomarkers and critical pathways. Int J Clin Exp Med. 8:7209–7219.
2015.PubMed/NCBI
|
|
20
|
Bustin S and Nolan T: Talking the talk,
but not walking the walk: RT-qPCR as a paradigm for the lack of
reproducibility in molecular research. Eur J Clin Invest.
47:756–774. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Daugas E, Nochy D, Ravagnan L, Loeffler M,
Susin SA, Zamzami N and Kroemer G: Apoptosis-inducing factor (AIF):
A ubiquitous mitochondrial oxidoreductase involved in apoptosis.
FEBS Lett. 476:118–123. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ohiro Y, Garkavtsev I, Kobayashi S,
Sreekumar KR, Nantz R, Higashikubo BT, Duffy SL, Higashikubo R,
Usheva A, Gius D, et al: A novel p53 inducible apoptogenic gene,
PRG3, encodes a homologue of the apoptosis-inducing factor (AIF).
FEBS Lett. 524:163–171. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Seth R, Yang C, Kaushal V, Shah SV and
Kaushal GP: p53-dependent caspase-2 activation in mitochondrial
release of apoptosis-inducing factor and its role in renal tubular
epithelial cell injury. J Biol Chem. 280:31230–31239. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Agarwal E, Chaudhuri A, Leiphrakpam PD,
Haferbier KL, Brattain MG and Chowdhury S: Akt inhibitor MK-2206
promotes anti-tumor activity and cell death by modulation of AIF
and Ezrin in colorectal cancer. BMC Cancer. 14:1452014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu JY, Zheng ZH, Son YO, Shi X, Jang YO
and Lee JC: Mycotoxin zearalenone induces AIF- and ROS-mediated
cell death through p53- and MAPK-dependent signaling pathways in
RAW264.7 macrophages. Toxicol In Vitro. 25:1654–1663. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jeong EG, Lee JW, Soung YH, Nam SW, Kim
SH, Lee JY, Yoo NJ and Lee SH: Immunohistochemical and mutational
analysis of apoptosis-inducing factor (AIF) in colorectal
carcinomas. APMIS. 114:867–873. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Skyrlas A, Hantschke M, Passa V, Gaitanis
G, Malamou-Mitsi V and Bassukas ID: Expression of
apoptosis-inducing factor (AIF) in keratoacanthomas and squamous
cell carcinomas of the skin. Exp Dermatol. 20:674–676. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sun Y, Zhang Y, Wang X, Blomgren K and Zhu
C: Apoptosis-inducing factor downregulation increased neuronal
progenitor, but not stem cell, survival in the neonatal hippocampus
after cerebral hypoxia-ischemia. Mol Neurodegener. 7:172012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xiong Z, Guo M, Yu Y, Zhang FF, Ge MK,
Chen GQ and Shen SM: Downregulation of AIF by HIF-1 contributes to
hypoxia-induced epithelial-mesenchymal transition of colon cancer.
Carcinogenesis. 37:1079–1088. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu H, Li J, Zhao Y and Liu D: TNFα-induced
downregulation of microRNA-186 contributes to apoptosis in rat
primary cardiomyocytes. Immunobiology. 222:778–784. 2017.
View Article : Google Scholar : PubMed/NCBI
|
